Ocular Hypertension
Links shared publicly online about this topic
Hypertension Community - Medpedia
medpedia.com — “This community is for patients, providers, caregivers and others interested in learning more about Hypertension (aka High Blood Pressure), Pulmonary Hypertension, Ocular Hypertensi on...” View full resource at medpedia.com
Most Recently Shared on September 24, 2009 at 6:36 pm By:
The Medpedia Project Health Site
Microchip in BP Pills Reminds Patients to Take Meds #HBP http://tinyurl.com/y99hkjl Share your thoughts here: http://tinyurl.com/y8nyq5x
Phase 2a study of AR-12286 for treatment of glaucoma and ocular hypertension - MPR
empr.com — “Aerie Pharmaceuticals announced positive results from a Phase 2a study of AR-12286 for the treatment of primary open angle glaucoma or ocular hypertension.” View full resource at empr.com
Most Recently Shared on October 22, 2009 at 3:15 pm By:
MPR News: Phase 2a study of AR-12286 for treatment of glaucoma and ocular hypertension: Aerie Pharmace.. http://bit.ly/3X4itl
Nutrition For Ocular Hypertension | LIVESTRONG.COM
livestrong.com — “Nutrition For Ocular Hypertension. Ocular hypertension is another term for having higher-than-normal pressure in your eyes. The pressure in your eyes, called intraocular pressure can interfere with your sight and th...” View full resource at livestrong.com
Most Recently Shared on May 27, 2011 at 9:46 am By:
Nutrition for Ocular Hypertension: Ocular hypertension is another term for having higher-than-normal pre... http://bit.ly/mo1rH3 #health
China approves pneumatic trabeculoplasty for glaucoma, ocular hypertension
osnsupersite.com — “FOUNTAIN HILLS, Ariz. " China's State Food and Drug Administration has approved pneumatic trabeculoplasty treatment for glaucoma and ocular hypertensi” View full resource at osnsupersite.com
Most Recently Shared on March 5, 2010 at 7:00 pm By:
#China approves pneumatic trabeculoplasty for #glaucoma, ocular hypertension: http://ow.ly/1eKFn
NICE guidance on managing chronic open angle glaucoma and ocular hypertension | Practice | Nursing Times
nursingtimes.net — “A member of the NICE guideline development group highlights the important issues from the latest evidence-based guideline for readers of Nursing Times” View full resource at nursingtimes.net
Most Recently Shared on July 9, 2009 at 2:52 pm By:
Practice: NICE guidance on managing chronic open angle glaucoma and ocular hypertension: A member of th.. http://bit.ly/qb50L
Patient adherence to brimonidine therapy low, study shows
osnsupersite.com — “Individual adherence to brimonidine topical treatment among a majority of patients with glaucoma or ocular hypertension was pharmacologically insuffic” View full resource at osnsupersite.com
Most Recently Shared on November 15, 2011 at 4:45 pm By:
#Glaucoma study: http://t.co/o6V5hFZ5 -- Patient adherence to brimonidine therapy low
New Rho-kinase inhibitor could become viable glaucoma treatment option
osnsupersite.com — “FORT LAUDERDALE, Fla. --" A Rho-kinase inhibitor significantly reduced IOP in patients with open-angle glaucoma and ocular hypertension, according to a” View full resource at osnsupersite.com
Most Recently Shared on May 2, 2011 at 4:22 pm By:
New #Rho-kinase inhibitor could become viable #glaucoma treatment option: http://ht.ly/4Lj1f
NDA Accepted for Saflutan for Glaucoma - ONA
oncologynurseadvisor.com — “Merck announced that the FDA has accepted its New Drug Application for Saflutan (tafluprost ophthalmic solution) for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.” View full resource at oncologynurseadvisor.com
Most Recently Shared on March 9, 2011 at 6:23 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
NDA Accepted for Saflutan for Glaucoma http://goo.gl/fb/aCszL
NDA Accepted for Saflutan for Glaucoma - MPR
empr.com — “Merck announced that the FDA has accepted its New Drug Application for Saflutan (tafluprost ophthalmic solution) for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.” View full resource at empr.com
Most Recently Shared on March 9, 2011 at 6:53 pm By:
MPR News: NDA Accepted for Saflutan for Glaucoma: Merck announced that the FDA has accepted its New Drug Applica... http://bit.ly/dFl7IR
NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer - Ophthalmology Times Europe
oteurope.com — “NicOx S.A. has signed an agreement with Pfizer Inc to reacquire the full development and commercialization rights to PF-03187207, which has completed two phase II studies in patients with primary open angle glaucoma and ocular hypertension. As part of this agreement, Pfizer has granted NicOx the right to access and use certain proprietary Xalatan (latanoprost) data.” View full resource at oteurope.com
Most Recently Shared on August 20, 2009 at 1:40 pm By:
Ophthalmology Times Ophthalmology and Health Magazine
NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer. http://ow.ly/kxUx
Massage may help reduce IOP after Ahmed glaucoma drainage device surgery
osnsupersite.com — “Digital ocular massage lowered IOP by 20% in some patients during the hypertensive phase after Ahmed glaucoma drainage device surgery, according to a” View full resource at osnsupersite.com
Most Recently Shared on March 22, 2010 at 3:10 pm By:
Massage may help reduce IOP after Ahmed #glaucoma drainage device surgery: http://ow.ly/1pnk0
Measurement of Optic Nerve Sheath Diameter for the Assessment of Risk of Raised Intracranial Pressure | Neurology
touchneurology.com — “Intracranial pressure, neurocritical care, ocular sonography, optic nerve sheath diameter, traumatic brain injury, intracranial hypertension, intracranial pressure monitoring, cerebral perfusion pressure, intracranial pressure value, cerebral venous” View full resource at touchneurology.com
Most Recently Shared on January 18, 2010 at 9:00 am By:
touchNEURO Health Site and Neurology
Measurement of Optic Nerve Sheath Diameter for the Assessment of Risk of Raised Intracranial Pressure http://ow.ly/XAXd
Allergan, Inc. Receives FDA Approval for Lumigan 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
drugs.com — “Lumigan (bimatoprost) is used for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Includes Lumigan side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on September 5, 2010 at 11:24 pm By:
FDA Approves Lumigan 0.01% for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients - http://bit.ly/9f4yUQ
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on September 3, 2009 at 1:40 pm By:
eyeonfda Pharma and Health Lawyer
Merck Launches SAFLUTAN® (tafluprost) in International Markets - http://bit.ly/fUbwR
Aerie Pharmaceuticals' ROCK Inhibitor, AR-12286, Demonstrates Positive Results In Glaucoma Patients In A Phase 2a Study
medicalnewstoday.com — “Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, announced positive results from a Phase 2a study of its Rho-kinase (ROCK)” View full resource at medicalnewstoday.com
Most Recently Shared on October 25, 2009 at 12:45 pm By:
MNT Clinical Trials Health News
Aerie Pharmaceuticals' ROCK Inhibitor, AR-12286, Demonstrates Positive Results In Glaucoma Patients In A Phase .. http://bit.ly/hHIWU
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Medpedia Project
Medpedia is a long-term project to advance collaborative, transparent health and medical knowledge.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Health & Medicine
Organizing general health resources shared by health experts and advocates into WisdomCards.
Advertisement
